Quinet E, Yang T P, Marinos C, Tall A
Department of Medicine, Columbia University, New York, New York 10032.
J Biol Chem. 1993 Aug 15;268(23):16891-4.
Alternative splicing of mRNA is often used as a regulatory switch, determining whether a functional protein is made or not. The plasma cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from high density lipoproteins to other lipoproteins. In addition to the mRNA encoding plasma CETP, human tissues contain an alternatively spliced variant in which exon 9-derived sequences are omitted. To determine a possible regulatory role of alternative splicing, COS cells were co-transfected with full-length and exon 9-deleted cDNAs. The exon 9-deleted protein was poorly secreted and inhibited the secretion of full-length CETP, due to formation of an intracellular heteromeric complex between full-length and exon 9-deleted proteins. The findings suggest a novel use of alternative splicing to generate a poorly secreted protein variant, which complexes with the active form and prevents its secretion by cells.
mRNA的可变剪接常被用作一种调控开关,决定是否产生功能性蛋白质。血浆胆固醇酯转运蛋白(CETP)介导胆固醇酯从高密度脂蛋白向其他脂蛋白的转运。除了编码血浆CETP的mRNA外,人体组织还含有一种可变剪接变体,其中省略了源自外显子9的序列。为了确定可变剪接可能的调控作用,将全长cDNA和缺失外显子9的cDNA共转染到COS细胞中。由于全长蛋白和缺失外显子9的蛋白之间形成了细胞内异源复合物,缺失外显子9的蛋白分泌较差,并抑制了全长CETP的分泌。这些发现表明可变剪接有了一种新用途,即产生一种分泌较差的蛋白质变体,该变体与活性形式形成复合物并阻止细胞分泌活性形式的蛋白质。